788
Participants
Start Date
September 6, 2022
Primary Completion Date
December 20, 2023
Study Completion Date
May 2, 2024
Freenome Test
Participants who provide informed consent, meet the eligibility criteria and provide a blood sample for this study will be enrolled.
Geisinger Bloomsburg Hospital, Bloomsburg
INOVA, Fairfax
Iredell Memorial Hospital, Statesville
MUSC, Charleston
MacLeod Center for Cancer Treatment and Research, Florence
Crisp Regional Hospital, Cordele
Cleveland Clinic, Cleveland
Silver Cross Hospital and Medical centers, Orland Park
Margaret Mary, Batesville
Henry Ford Health, Detroit
Aurora St. Luke's Medical Center, Milwaukee
Allina Health Cancer Institute, Minneapolis
Winona Health System, Winona
Advocate Lutheran General Hospital, Park Ridge
Hannibal Regional Hospital, Hannibal
University Health Truman Medical Center, Kansas City
North Kansas City Hospital, North Kansas City
Carroll County Memorial Hospital, Carrollton
Elligo Health Research, Inc., Austin
Renown Regional Medical Center, Reno
Oregon Health and Science University, Portland
Inspira Medical Center, Mullica Hill
St Joseph University, Paterson
Freenome Holdings Inc.
INDUSTRY